AH

Alan Houghton

SR Sloan Kettering Institute For Cancer Research: 26 patents #5 of 644Top 1%
SI Sloan-Kettering Institute: 1 patents #9 of 35Top 30%
📍 New York, NY: #504 of 20,192 inventorsTop 3%
🗺 New York: #4,427 of 115,490 inventorsTop 4%
Overall (All Time): #139,810 of 4,157,543Top 4%
28
Patents All Time

Issued Patents All Time

Showing 1–25 of 28 patents

Patent #TitleCo-InventorsDate
8021666 Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen Maria Lia Palomba, Jedd D. Wolchok, David A. Scheinberg, Wendy K. Roberts 2011-09-20
7618637 Heat shock protein-based vaccines and immunotherapies James Rothman, F. Ulrich Hartl, Mee Hoe, Yoshizumi Takechi, Mark Mayhew 2009-11-17
7556805 Compositions for treatment of melanoma and method of using same Philip J. Bergman, Jedd D. Wolchok 2009-07-07
6805862 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof Paul Chapman 2004-10-19
6773707 Heat shock protein-based vaccines and immunotherapies James Rothman, Franz-Ulrich Hartl, Mee Hoe, Yoshizumi Takechi, Mark Mayhew 2004-08-10
6761892 Heat shock protein-based vaccines and immunotherapies James Rothman, Franz-Ulrich Hartl, Mee Hoe, Yoshizumi Takechi, Mark Mayhew 2004-07-13
6719974 Heat shock protein-based vaccines and immunotherapies James Rothman, Franz-Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2004-04-13
6673348 Heat shock protein-based vaccines and immunotherapies James Rothman, F. Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2004-01-06
6663868 Heat shock protein-based vaccines and immunotherapies James Rothman, Franz-Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2003-12-16
6656679 Heat shock protein-based vaccines and immunotherapies James Rothman, F. Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2003-12-02
6641812 Heat shock protein-based vaccines and immunotherapies James Rothman, F. Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2003-11-04
6605464 Method of treatment of cancer and infectious disease and compositions useful in same James Rothman, F. Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2003-08-12
6432402 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof Paul Chapman 2002-08-13
6331299 Method for treatment of cancer and infectious disease and compositions useful in same James Rothman, F. Ulrich Hartl, Mee Hoe, Yoshizumi Takeuchi, Mark Mayhew 2001-12-18
6328969 Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen Clarissa Naftzger, Setaluri Vijayasaradhi 2001-12-11
6294378 Method and reagents for genetic immunization Shirley M. Bartido, Yiquing Xu, Siqun Wang 2001-09-25
6168946 gp75 as a tumor vaccine for melanoma Setaluri Vijayasaradhi 2001-01-02
5792455 Anti-idiotypic antibody vaccines Paul Chapman 1998-08-11
5773291 Non-melanotytic mammalian cell constitutively expressing biologically active human tyrosinase and use thereof Brigitte Bouchard 1998-06-30
5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD.sub.3 and hybridoma producing said antibody Paul Chapman 1996-06-25
5104652 Compositions and method for treatment of cancer using monoclonal antibody against G.sub.D3 ganglioside together with IL-2 Karl Welte, Glenn A. Miller, Paul Chapman, Lloyd J. Old 1992-04-14
4806628 Monoclonal antibodies against melanocytes Anthony P. Albino, J. Gregory Cairncross, Magdalena Eisinger, Lloyd J. Old 1989-02-21
4727021 Human monoclonal antibodies to cytokeratin Richard J. Cote, Timothy M. Thomson, Herbert F. Oettgen, Lloyd J. Old 1988-02-23
4695538 Human monoclonal antibodies to cell surface antigens Richard J. Cote, Timothy M. Thomson, Herbert F. Oettgen, Lloyd J. Old, Carlos C. Cardo 1987-09-22
4693966 Human monoclonal antibodies from lymphocytes of patients with malignant melanoma Hannah Brooks, Richard J. Cote, Herbert F. Oettgen, Lloyd J. Old 1987-09-15